Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272025
Status:
TERMINATED
Last Update Posted:
2015-12-16
First Post:
2006-01-03
Brief Title:
Treatment Resistant Bipolar Depression
Sponsor:
Queens University
Organization:
Queens University
Study Overview
Official Title:
Six Week Double Blind Randomized Trial of Escitalopram Add On for Treatment Resistant Bipolar Depression
Status:
TERMINATED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lundbeck withdrew committment - expiring patents and prolonged inactivity
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine if adding Escitalopram to current mood stabilizer MS or atypical antipsychotic AA will improve in rates similar to or better than adding a placebo inactive pillin resistant bipolar patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None